中南药学2024,Vol.22Issue(5) :1300-1304.DOI:10.7539/j.issn.1672-2981.2024.05.029

二氢杨梅素肝脏疾病保护作用及机制研究进展

Research progress in the effect of dihydromyricetin on the prevention and treatment of liver diseases and related mechanism

康萌 李雪梅 万静之 李澳忠 刘启玲 李影娜 秦绪军
中南药学2024,Vol.22Issue(5) :1300-1304.DOI:10.7539/j.issn.1672-2981.2024.05.029

二氢杨梅素肝脏疾病保护作用及机制研究进展

Research progress in the effect of dihydromyricetin on the prevention and treatment of liver diseases and related mechanism

康萌 1李雪梅 1万静之 1李澳忠 1刘启玲 1李影娜 2秦绪军3
扫码查看

作者信息

  • 1. 陕西中医药大学公共卫生学院,陕西 咸阳 712046
  • 2. 珠海高新技术产业开发区人民医院,广东 珠海 519085
  • 3. 西北工业大学生命学院,西安 710072
  • 折叠

摘要

二氢杨梅素是一种主要存在于葡萄科蛇葡萄属植物中的黄酮类化合物,具有抗氧化、抗炎、抗肿瘤、抗病原微生物、抗衰老、解酒保肝、防治心脑血管及代谢性疾病等多种药理学作用.近年来,二氢杨梅素对肝脏疾病包括急性肝损伤、酒精性肝病、代谢功能障碍相关的脂肪变性肝病、病毒性肝炎、肝纤维化以及肝癌等的保护作用得到了大量的研究和报道.本文对二氢杨梅素对肝脏疾病的保护作用及机制进行综述,以期为二氢杨梅素相关药物研发及临床防治肝脏疾病提供参考.

Abstract

Dihydromyricetin is a flavonoid compound mainly present in plants of the Ampelopsis genus in grape family.It has various pharmacological effects such as antioxidation,anti-inflammation,anti-tumor,anti-microbe,anti-aging,anti-alcohol and liver protection,prevention and treatment of cardiovascular,cerebrovascular,and metabolic diseases.Recently,the protective effects of dihydromyricetin on liver diseases including acute liver injury,alcoholic liver disease,metabolic dysfunction-associated steatotic liver disease,viral hepatitis,liver fibrosis,and liver cancer have been extensively studied.This article reviewed the protective effect and mechanism of dihydromyricetin on liver diseases,to provide reference for the development of dihydromyricetin-related drugs and products,as well as the clinical prevention and treatment of liver diseases.

关键词

二氢杨梅素/抗氧化/氧化应激/药理作用

Key words

dihydromyricetin/antioxidation/oxidative stress/pharmacological effect

引用本文复制引用

基金项目

陕西省自然科学基础研究计划(2024JC-ZDXM-50)

陕西省重点研发计划(2018SF-014)

出版年

2024
中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
参考文献量36
段落导航相关论文